SU1494274A1 - Method of preparing the factor inhibiting macrophage and leukocyte migration activity - Google Patents

Method of preparing the factor inhibiting macrophage and leukocyte migration activity

Info

Publication number
SU1494274A1
SU1494274A1 SU4263733/14A SU4263733A SU1494274A1 SU 1494274 A1 SU1494274 A1 SU 1494274A1 SU 4263733/14 A SU4263733/14 A SU 4263733/14A SU 4263733 A SU4263733 A SU 4263733A SU 1494274 A1 SU1494274 A1 SU 1494274A1
Authority
SU
USSR - Soviet Union
Prior art keywords
effect
preparing
leukocyte migration
migration activity
factor inhibiting
Prior art date
Application number
SU4263733/14A
Other languages
Russian (ru)
Inventor
Л.В. Ганковская
Л.В. Ковальчук
Н.А. Гвоздева
М.В. Карасева
С.Н. Москвина
Original Assignee
2-й Московский государственный медицинский институт им.Н.И.Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 2-й Московский государственный медицинский институт им.Н.И.Пирогова filed Critical 2-й Московский государственный медицинский институт им.Н.И.Пирогова
Priority to SU4263733/14A priority Critical patent/SU1494274A1/en
Application granted granted Critical
Publication of SU1494274A1 publication Critical patent/SU1494274A1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

FIELD: immunochemistry. SUBSTANCE: method involves separation of pig peripheral blood in gradient ficoll-verographin at density 1.078 g/cm. The isolated lymphocyte fraction is treated with phytohemagglutinin, supernatant is cultured, cell-free supernatant is taken off, concentrated by ultrafiltration on diaphragm filters PM-10 and separated using Sephadex G-100. Two active fractions of molecular mass 60-70 and 20-30 kDa were obtained. These fractions effect on motility of phagocytic cells and show accelerating effect of wound healing processes. EFFECT: simplified method.
SU4263733/14A 1987-06-19 1987-06-19 Method of preparing the factor inhibiting macrophage and leukocyte migration activity SU1494274A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4263733/14A SU1494274A1 (en) 1987-06-19 1987-06-19 Method of preparing the factor inhibiting macrophage and leukocyte migration activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4263733/14A SU1494274A1 (en) 1987-06-19 1987-06-19 Method of preparing the factor inhibiting macrophage and leukocyte migration activity

Publications (1)

Publication Number Publication Date
SU1494274A1 true SU1494274A1 (en) 1997-10-10

Family

ID=60526784

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4263733/14A SU1494274A1 (en) 1987-06-19 1987-06-19 Method of preparing the factor inhibiting macrophage and leukocyte migration activity

Country Status (1)

Country Link
SU (1) SU1494274A1 (en)

Similar Documents

Publication Publication Date Title
US4632980B1 (en)
AU4992985A (en) Method and system for removing immunosuppressive components from the blood of mammals
PH25120A (en) Replicable expression vehicle and process of preparation thereof
EP0487627A4 (en) Wound healing preparations containing heparanase
NO166943C (en) ANALOGY PROCEDURE FOR PREPARING ENZYMESRESISTENT IMMUNO MODULATING PEPTIDES.
JPS5598118A (en) Preparation of type-2 interferon and drug containing the same
CA1267496C (en) Purification and activation of proteins from insoluble inclusion bodies
IL94128A0 (en) Production of vascular endothelial cell growth factor and dna encoding same
IE840493L (en) Biosynthetically produced human nerve growth factor.
NO176665C (en) Process for the preparation of non-glycosylated IL-6 and vector for its secretion
EP0311283A3 (en) Process for obtaining concentrates having a high alpha-lactalbumin content from whey
ATE72937T1 (en) METHOD OF TREATMENT OF WHEY PROTEIN.
AP8700068A0 (en) Vaccine and method of preparation.
ES8606885A1 (en) Homogeneous immune interferon fragment.
UA6025A1 (en) METHOD OF OBTAINING FACTORS 1,2,3,4,5 TEICHOMYCIN AND THEIR SALTS 2
ES8506196A1 (en) Process for the preparation of a biologically active extract.
EP0087087A3 (en) A method of manufacturing biological active substance
ES8107253A1 (en) Material produced from cross-linked ionic chitin derivative, its preparation and use.
ES8503238A1 (en) Process for the preparation of protein concentrates and nutriments by processing animal blood
ES474697A1 (en) Interferon product, process for its preparation and pharmaceutical preparations.
SU1494274A1 (en) Method of preparing the factor inhibiting macrophage and leukocyte migration activity
ES8302016A1 (en) Process for the preparation of blood plasma fractions.
EP0104831A3 (en) Tissue culture and cell growth-promoting material and methods for the manufacture and use thereof
ES8504210A1 (en) Process for the preparation of globin from hemoglobin, and globin obtained in this process.
EP0125125A2 (en) An agent for inhibiting the proliferation of malignant tumour cells and a process for the preparation thereof